• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏淀粉样变性合并严重继发性二尖瓣和三尖瓣反流患者的双导管缘对缘修复术:病例报告

Dual transcatheter edge-to-edge repair in a patient with cardiac amyloidosis and severe secondary mitral and tricuspid regurgitation: a case report.

作者信息

Vogel Julia, Luedike Peter, Mahabadi Amir Abbas, Rassaf Tienush, Michel Lars

机构信息

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstr. 55, 45147  Essen, Germany.

Department of Cardiology and Intensive Care Medicine, Niels-Stensen-Kliniken, Marienhospital Osnabrück, Bischofsstr. 1, 49074 Osnabrück, Germany.

出版信息

Eur Heart J Case Rep. 2024 Dec 12;8(12):ytae601. doi: 10.1093/ehjcr/ytae601. eCollection 2024 Dec.

DOI:10.1093/ehjcr/ytae601
PMID:39669552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11635633/
Abstract

BACKGROUND

Mitral and tricuspid regurgitation in patients with cardiac amyloidosis (CA) pose significant diagnostic and therapeutic challenges due to its non-specific symptoms and limited treatment options. Transcatheter edge-to-edge repair (TEER) is complicated by altered cardiac geometry, advanced restriction, and potential amyloid valve deposits.

CASE SUMMARY

We present the case of dual TEER in a 79-year-old male with advanced transthyretin cardiac amyloidosis (ATTR-CA) and severe symptomatic mitral and tricuspid regurgitation. In a staged approach, TEER for both the mitral and tricuspid valves was successfully conducted, resulting in improved valvular function and symptom relief. Transvalvular gradients were 5 mmHg for mitral valve and 2 mmHg for tricuspid valve, each with mild residual regurgitation, improved clinical status, and regressive natriuretic peptides.

DISCUSSION

This case underscores the feasibility of dual TEER in CA patients with valvular involvement. Further research is necessary to optimize treatment strategies and address the multifaceted nature of this complex disease.

摘要

背景

心脏淀粉样变性(CA)患者的二尖瓣和三尖瓣反流因其非特异性症状和有限的治疗选择而带来重大的诊断和治疗挑战。经导管缘对缘修复(TEER)因心脏几何形状改变、严重限制以及潜在的淀粉样瓣膜沉积物而变得复杂。

病例摘要

我们报告了一名79岁男性患有晚期转甲状腺素蛋白心脏淀粉样变性(ATTR-CA)以及严重症状性二尖瓣和三尖瓣反流的双TEER病例。采用分期方法,成功对二尖瓣和三尖瓣进行了TEER,瓣膜功能得到改善,症状缓解。二尖瓣跨瓣压差为5 mmHg,三尖瓣为2 mmHg,均伴有轻度残余反流,临床状况改善,利钠肽水平下降。

讨论

该病例强调了双TEER在患有瓣膜受累的CA患者中的可行性。有必要进行进一步研究以优化治疗策略并应对这种复杂疾病的多方面性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fd/11635633/2e231361b71a/ytae601f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fd/11635633/f3c0f93ba9fd/ytae601il2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fd/11635633/a5b962188fef/ytae601f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fd/11635633/2e231361b71a/ytae601f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fd/11635633/f3c0f93ba9fd/ytae601il2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fd/11635633/a5b962188fef/ytae601f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fd/11635633/2e231361b71a/ytae601f2.jpg

相似文献

1
Dual transcatheter edge-to-edge repair in a patient with cardiac amyloidosis and severe secondary mitral and tricuspid regurgitation: a case report.心脏淀粉样变性合并严重继发性二尖瓣和三尖瓣反流患者的双导管缘对缘修复术:病例报告
Eur Heart J Case Rep. 2024 Dec 12;8(12):ytae601. doi: 10.1093/ehjcr/ytae601. eCollection 2024 Dec.
2
Transcatheter Tricuspid Valve Edge-to-Edge Repair in Cardiac Wild-Type Transthyretin Amyloidosis.心脏野生型转甲状腺素蛋白淀粉样变性的经导管三尖瓣缘对缘修复术
JACC Case Rep. 2025 Mar 19;30(6 Pt 2):103414. doi: 10.1016/j.jaccas.2025.103414.
3
Transcatheter edge-to-edge repair for tricuspid valve regurgitation in apolipoprotein A-I-associated cardiac amyloidosis: case report.经导管边缘对边缘修复术治疗载脂蛋白A-I相关心脏淀粉样变性中的三尖瓣反流:病例报告
Eur Heart J Case Rep. 2023 Nov 30;7(12):ytad582. doi: 10.1093/ehjcr/ytad582. eCollection 2023 Dec.
4
Predictors of Residual Severe Tricuspid Regurgitation After Transcatheter Mitral Valve Repair.经导管二尖瓣修复术后残留严重三尖瓣反流的预测因素
J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):100612. doi: 10.1016/j.jscai.2023.100612. eCollection 2023 Jul-Aug.
5
Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair.二尖瓣经导管缘对缘修复术中的三尖瓣反流及其结局
Eur Heart J. 2025 Apr 15;46(15):1415-1427. doi: 10.1093/eurheartj/ehae924.
6
Two 'firsts' in a patient with tricuspid valve infective endocarditis following edge-to-edge repair: a case report.一例经边对边修复术后发生三尖瓣感染性心内膜炎患者的两个“首例”:病例报告
Eur Heart J Case Rep. 2024 Apr 17;8(4):ytae181. doi: 10.1093/ehjcr/ytae181. eCollection 2024 Apr.
7
CardioTwins: case report of a transcatheter mitral and tricuspid valve implantation in one patient.心脏双胞胎:一例患者经导管二尖瓣和三尖瓣植入术的病例报告。
Eur Heart J Case Rep. 2024 Jul 17;8(7):ytae336. doi: 10.1093/ehjcr/ytae336. eCollection 2024 Jul.
8
Continuous atrial pressure monitoring via steerable guide catheter in transcatheter mitral and tricuspid edge-to-edge repair.经导管二尖瓣和三尖瓣边缘对边缘修复术中通过可操纵引导导管进行连续心房压力监测。
Catheter Cardiovasc Interv. 2022 May;99(6):1796-1806. doi: 10.1002/ccd.30109. Epub 2022 Feb 3.
9
Impact of Tricuspid Regurgitation on Outcomes of Mitral Valve Surgery after Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术后三尖瓣反流对二尖瓣手术结局的影响。
Semin Thorac Cardiovasc Surg. 2024;36(1):11-25. doi: 10.1053/j.semtcvs.2022.06.021. Epub 2022 Aug 3.
10
Clinical Impact of Tricuspid Regurgitation on Transcatheter Edge-to-Edge Mitral Valve Repair for Mitral Regurgitation.三尖瓣反流对二尖瓣反流经导管缘对缘修复术的临床影响。
Cardiovasc Revasc Med. 2022 Aug;41:1-9. doi: 10.1016/j.carrev.2022.01.027. Epub 2022 Feb 5.

引用本文的文献

1
Safety and Feasibility of Transcatheter Edge-to-Edge Repair of Mitral Regurgitation in Cardiac Amyloidosis.心脏淀粉样变性中经导管二尖瓣反流边缘对边缘修复的安全性和可行性
JACC Adv. 2025 Jul 16;4(8):101998. doi: 10.1016/j.jacadv.2025.101998.

本文引用的文献

1
Valvular heart disease in patients with cardiac amyloidosis.心脏淀粉样变患者的瓣膜性心脏病。
Heart Fail Rev. 2024 Jan;29(1):65-77. doi: 10.1007/s10741-023-10350-1. Epub 2023 Sep 22.
2
Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study.经导管缘对缘修复术治疗 5000 例继发性二尖瓣反流患者:COAPT 上市后研究。
J Am Coll Cardiol. 2023 Sep 26;82(13):1281-1297. doi: 10.1016/j.jacc.2023.07.015.
3
Transcatheter Repair for Patients with Tricuspid Regurgitation.经导管三尖瓣反流修复术治疗患者。
N Engl J Med. 2023 May 18;388(20):1833-1842. doi: 10.1056/NEJMoa2300525. Epub 2023 Mar 4.
4
Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis.经导管三尖瓣修复术治疗心脏淀粉样变性患者的初步经验。
ESC Heart Fail. 2023 Apr;10(2):1003-1012. doi: 10.1002/ehf2.14262. Epub 2022 Dec 13.
5
Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients.经导管缘对缘修复术治疗高手术风险退行性二尖瓣反流的随机对照研究。
JACC Cardiovasc Interv. 2022 Dec 26;15(24):2523-2536. doi: 10.1016/j.jcin.2022.09.005. Epub 2022 Sep 17.
6
Unveiling Cardiac Amyloidosis, its Characteristics, and Outcomes Among Patients With MR Undergoing Transcatheter Edge-to-Edge MV Repair.揭示心脏淀粉样变性在接受经导管缘对缘二尖瓣修复术的 MR 患者中的特征和结局。
JACC Cardiovasc Interv. 2022 Sep 12;15(17):1748-1758. doi: 10.1016/j.jcin.2022.06.009. Epub 2022 Aug 22.
7
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.心脏淀粉样变性的诊断与治疗:欧洲心脏病学会心肌与心包疾病工作组的立场声明
Eur Heart J. 2021 Apr 21;42(16):1554-1568. doi: 10.1093/eurheartj/ehab072.
8
Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.主动脉瓣狭窄与心脏淀粉样变性:美国心脏病学会评论专题周报
J Am Coll Cardiol. 2019 Nov 26;74(21):2638-2651. doi: 10.1016/j.jacc.2019.09.056.
9
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.经皮修复或药物治疗继发性二尖瓣反流。
N Engl J Med. 2018 Dec 13;379(24):2297-2306. doi: 10.1056/NEJMoa1805374. Epub 2018 Aug 27.
10
Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful?心脏转甲状腺素蛋白淀粉样变的标准心力衰竭药物:有益还是有害?
Amyloid. 2017 Mar;24(sup1):132-133. doi: 10.1080/13506129.2016.1272453.